8.15000 EUR
0.416
5.38%
Last update Dec 15, 9:34 AM CET
Main market
Day range
7.34200
8.15000
Previous close
7.73400
Open
7.34200
Access this stock data via API
Subscribe
Intellia Therapeutics Inc.
8.15
0.42
5.38%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 11.7M 12.1M 14.2M 11.0M
Cost of revenue
Gross profit
Operating expense
Research & development 80.7M 82.7M 92.4M 99.6M
Selling general and admin 26.0M 23.2M 24.7M 27.6M
Other operating expenses
Operating income -95.0M -93.7M -102.9M -116.2M
Non operating interest income
Income 5.7M 6.3M 7.3M 9.1M
Expense
Other income expense 2.9M 1.1M -1.8M -2.6M
Pretax income -86.3M -86.2M -97.4M -109.8M
Tax provision
Net income -86.3M -86.2M -97.4M -109.8M
Basic EPS -1.0 -1.1 -1.3
Diluted EPS -1.0 -1.1 -1.3
Basic average shares 88.4M 88.2M 86.8M
Diluted average shares 88.4M 88.2M 86.8M
EBITDA -93.7M -92.7M -99.0M -111.4M
Net income from continuing op. -86.3M -86.2M -97.4M -109.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 38 minutes

10:21
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).